Bay Area Biotech Committed to Advancing Novel Therapies for Unmet Needs
Spruce Biosciences is a clinical-stage biopharmaceutical based in San Francisco, California. Our mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis (the “stress pathway”). As a forward-thinking Bay Area biotech, we are committed to transforming the quality of life for patients who have been underserved by scientific innovation.
Spruce’s lead program is being developed to serve the chronic and acute needs of patients with Congenital Adrenal Hyperplasia.